!['Under-trial antibiotic cleared superbug infection in 5 days' 'Under-trial antibiotic cleared superbug infection in 5 days'](https://cdn.magzter.com/1591660889/1668291454/articles/Ytbj_Ijme1668294115745/UNDERTRIAL-ANTIBIOTIC-CLEARED-SUPERBUG-INFECTION-IN-5-DAYS.jpg)
The Indian Council for Medical Research's (ICMR)’s fifth detailed report on antimicrobial resistance (AMR) trends and patterns showed that many ICU patients no longer benefit from carbapenem, a powerful antibiotic used to treat pneumonia and septicemia.
Resistance level is increasing by 5% to 10% every year for broad-spectrum antimicrobials, mainly due to discriminate use leading to resistance later one.
“India has high rates of multi-drug resistance among enterobacterales and gram-negative non-fermenters like Acinetobacter baumanii and Pseudomonas aeruginosa. New treatment options are urgently needed for such multi or extremely drug-resistant pathogens,” said ICMR’s senior scientist Kamini Walia, who coordinates antimicrobial resistance and diagnostics initiatives across the country.
هذه القصة مأخوذة من طبعة November 13, 2022 من The Times of India Mumbai.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة November 13, 2022 من The Times of India Mumbai.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول